This paradox in hepatic insulin resistance is that insulin fails to suppress hepatic glucose production, yet it continues to stimulate lipogenesis, resulting in hyperglycemia, hyperlipidemia, hepatic steatosis, and type 2 diabetes [30,32]. Here, INS is linked to fatty liver disease.